Ardelyx Analyst Ratings
Wedbush Adjusts Ardelyx's Price Target to $11 From $15, Keeps Outperform Rating
Ardelyx Analyst Ratings
Ardelyx Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Ardelyx (ARDX), Cogent Biosciences (COGT) and Immunocore Holdings (IMCR)
Analysts Offer Insights on Healthcare Companies: Ardelyx (ARDX), Oric Pharmaceuticals (ORIC) and Cellectis SA (CLLS)
Ardelyx Analyst Ratings
Ardelyx Analyst Ratings
Wedbush Remains a Buy on Ardelyx (ARDX)
Piper Sandler Sticks to Their Buy Rating for Ardelyx (ARDX)
Strong Launch and Unique Product Positioning Lead to Buy Rating for Ardelyx
Piper Sandler Sticks to Its Buy Rating for Ardelyx (ARDX)
Ardelyx Analyst Ratings
Ardelyx Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Cogent Biosciences (COGT), Lantheus (LNTH) and Ardelyx (ARDX)
Ardelyx Analyst Ratings
Ardelyx's Growth Trajectory: Buoyant Sales Projections and Market Expansion Drive Buy Rating
Analysts Offer Insights on Healthcare Companies: Halozyme (HALO), NeoGenomics (NEO) and Ardelyx (ARDX)
Analysts' Top Healthcare Picks: Ardelyx (ARDX), Generation Bio (GBIO)
Wedbush Maintains Outperform on Ardelyx, Raises Price Target to $13